NEWS

Germany hits pause again on AstraZeneca after 31 reports of rare blood clots, 9 deaths

Updated: March 31, 2021 at 4:57 am EST  See Comments

LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.

March 31, 2020 (Children’s Health Defense) – Authorities in Munich and Berlin today suspended the use of AstraZeneca’s COVID vaccine for those under 60 after Germany’s vaccine regulator reported 31 cases of a rare brain blood clot, nine of which resulted in deaths, ABC News reported.

All but two of the cases involved women 20 to 63 years old, according to the Paul Ehrlich Institute.

The decision was made as a precaution ahead of a meeting scheduled for later today with representatives from all of Germany’s 16 states, said Berlin’s top health official, Dilek Kalayci, who also said further recommendations are expected to be made by national medical regulators.

Kalayci said the suspension of AstraZeneca vaccines for younger people was a precautionary measure and that people needed to “treat it carefully and wait for the talks taking place at the federal level.”

Earlier Tuesday, two state-owned hospitals in Berlin announced they had stopped giving AstraZeneca’s COVID vaccine to female staff 55 years old and under, and heads of five university hospitals in western Germany called for a temporary halt to the vaccine for all younger women, citing the blood

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors

Advertisement
Inspirational Finished Christian Pocket Knife - 3 Inch Blade

LEAVE A REPLY

Please enter your comment!
Please enter your name here

A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Christian Journal and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.